| Neurology Alliance S.c. | |
|
2424 S 90th St Suite 504 West Allis WI 53227-2455 | |
| (414) 328-7489 | |
| (414) 328-7266 |
| Full Name | Neurology Alliance S.c. |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2424 S 90th St, West Allis, Wisconsin |
| Authorized Official Name and Position | Arshad Ahmed (OWNER) |
| Authorized Official Contact | 4143287489 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Neurology Alliance S.c. 2424 S 90th St Suite 504 West Allis WI 53227-2455 Ph: (414) 328-7489 | Neurology Alliance S.c. 2424 S 90th St Suite 504 West Allis WI 53227-2455 Ph: (414) 328-7489 |
| NPI Number | 1194963504 |
|---|---|
| Provider Enumeration Date | 01/23/2009 |
| Last Update Date | 03/25/2015 |
| Medicare PECOS PAC ID | 0749326684 |
|---|---|
| Medicare Enrollment ID | O20091007000612 |
News Archive
Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.
Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194963504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0600X | Psychiatry & Neurology - Clinical Neurophysiology | (* (Not Available)) | Primary |
| Provider Name | Arshad Ahmed |
|---|---|
| Provider Type | Practitioner - Neurology |
| Provider Identifiers | NPI Number: 1013982149 PECOS PAC ID: 4688613110 Enrollment ID: I20050425001231 |
News Archive
Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.
Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.
› Verified 6 days ago
| Provider Name | Elizabeth M Sharpee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457754137 PECOS PAC ID: 6800110974 Enrollment ID: I20150120001161 |
News Archive
Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.
Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.
› Verified 6 days ago
| Provider Name | Lee D Klemens |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568867232 PECOS PAC ID: 7214258730 Enrollment ID: I20150609000475 |
News Archive
Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.
Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.
› Verified 6 days ago
News Archive
Recent news coverage has focused on a delay until 2015 for the overhaul's provision that limits out-of-pocket costs for some patients.
In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.
Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.
Research shows low adherence to imatinib in Indian patients with chronic myeloid leukaemia, with an association between nonadherence and worse symptom burden related to treatment.
Spinifex Pharmaceuticals, an Australian pain drug development company, today announces the presentation of new data from a study of EMA401 in a model of diabetic neuropathy.
› Verified 6 days ago
Stress Management & Mental Health Clinics Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10201 W Lincoln Ave, # 308, West Allis, WI 53227 Phone: 414-329-7000 Fax: 414-329-7010 | |
Walter K T Wong Md Sc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2424 S 90th St, Ste. 202, West Allis, WI 53227 Phone: 414-328-7646 Fax: 414-328-7699 | |
Temenos Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7441 West Greenfield Avenue, West Allis, WI 53214 Phone: 707-443-3384 Fax: 707-443-3204 | |
Advancing Abilities Of Wisconsin Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10909 W Greenfield Ave, Suite 207, West Allis, WI 53214 Phone: 414-259-0021 Fax: 844-315-9207 | |
Social Rehabilitation And Residential Resources, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9330 W Lincoln Ave Ste 21, West Allis, WI 53227 Phone: 414-546-6880 Fax: 414-546-6234 | |
Act Counseling Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 9401 W Beloit Rd Ste 314, West Allis, WI 53227 Phone: 414-539-4862 Fax: 414-240-0761 |